Pharmaceutical giant GSK has announced plans to close its main research and development hub in Stevenage, Hertfordshire, in favour of a new flagship facility in Cambridge.
This strategic move is part of a broader initiative to slash costs by £1.9 billion, freeing up capital for future investment plans.